HomeLIA • FRA
add
LivaNova PLC
Previous close
€58.50
Day range
€56.00 - €56.00
Year range
€29.60 - €59.00
Market cap
3.54B USD
Avg Volume
1.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 360.92M | 12.15% |
Operating expense | 194.07M | 16.00% |
Net income | 30.91M | -44.70% |
Net profit margin | 8.56 | -50.72% |
Earnings per share | 0.86 | 6.17% |
EBITDA | 58.88M | -0.28% |
Effective tax rate | -11.88% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 635.55M | 48.20% |
Total assets | 2.61B | 3.98% |
Total liabilities | 1.41B | 18.54% |
Total equity | 1.20B | — |
Shares outstanding | 54.69M | — |
Price to book | 2.66 | — |
Return on assets | 4.53% | — |
Return on capital | 7.14% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 30.91M | -44.70% |
Cash from operations | 82.40M | 4.69% |
Cash from investing | -30.26M | -182.58% |
Cash from financing | -62.88M | -1,725.90% |
Net change in cash | -10.53M | -118.47% |
Free cash flow | 39.80M | -58.51% |
About
LivaNova, plc is an American medical device manufacturer based in the UK. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN". Wikipedia
Founded
1987
Website
Employees
3,300
